Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Feb 26, 2025 · 10-K · 57 days after period end · 0001493152-25-008383
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$1.52M | -$1.55M | $893.46K | -$177.74K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Feb 26, 2025 · 57 d after period end
